Waters Corporation’s Q2 results were met with a positive market reaction, driven by strong organic growth and momentum from its recently acquired Biosciences and Diagnostic Solutions businesses. Management pointed to robust demand across pharmaceutical, academic, and government markets, as well as the successful integration of new product launches. CEO Udit Batra highlighted that, "GLP-1 testing part of the business grew over 40% this quarter," with broad-based contributions across regions. The company also credited cross-divisional collaboration and improvements in commercial execution for boosting performance.
Is now the time to buy WAT? Find out in our full research report (it’s free for active Edge members).
Waters Corporation (WAT) Q2 CY2026 Highlights:
- Revenue: $1.65 billion vs analyst estimates of $1.62 billion (113% year-on-year growth, 1.3% beat)
- Adjusted EPS: $3.05 vs analyst estimates of $3.01 (1.4% beat)
- Revenue Guidance for Q3 CY2026 is $1.75 billion at the midpoint, roughly in line with what analysts were expecting
- Management slightly raised its full-year Adjusted EPS guidance to $14.55 at the midpoint
- Operating Margin: -5.2%, down from 24.4% in the same quarter last year
- Organic Revenue rose 7% year on year (beat)
- Market Capitalization: $40.43 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Waters Corporation’s Q2 Earnings Call
- Vijay Kumar (Evercore ISI) asked about sustainability of mid-single-digit growth in the acquired businesses. CEO Udit Batra said execution remains on track, citing product launches and leadership changes as drivers to exit the year above 6% growth.
- Elizabeth Koslosky (Goldman Sachs) requested details on the pricing initiatives’ contribution to guidance. CFO Amol Chaubal explained that 90 basis points of price realization were achieved, with further gains targeted through deal desk implementations and contract compliance.
- Tycho Peterson (Jefferies) inquired about Flow Research turnaround efforts, especially in China. Batra described localized manufacturing, a broadened portfolio in Q4, and new commercial leadership as key to future growth in the region.
- Subhalaxmi Nambi (Guggenheim) asked about changes to discounting processes and the impact on competitiveness. Batra said the new deal desk model increases speed and clarity, with early benefits seen in pricing discipline.
- Dan Leonard (RBC Capital Markets) questioned the sustainability of BD’s growth and the impact of seasonal dynamics. Chaubal clarified that seasonality and past inventory build explain quarter-to-quarter variation, but the second half should show accelerating momentum.
Catalysts in Upcoming Quarters
In future quarters, the StockStory team will be watching (1) the pace of adoption and customer feedback for the FACSDiscover A7 and BACTEC FXI launches, (2) whether localized manufacturing and leadership changes in China can turn recent improvements into sustained growth, and (3) tangible progress on reshoring-driven equipment demand in the U.S. Further, we will monitor the company’s ability to execute on pricing and cost-control initiatives as margin pressures persist.
Waters Corporation currently trades at $411.77, up from $374.74 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).
The Best Stocks for High-Quality Investors
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
